NYSE · Medical - Devices
SNN (SNN) Stock
$28.97
+0.73%
NYSE: SNN
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
GlobeNewswire · Jul 15, 2026
New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
GlobeNewswire · Jul 9, 2026
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
GlobeNewswire · Jul 9, 2026
Alkami Technology, Diebold Nixdorf, and 3 More Stocks See Action From Activist Investors.
Barrons.com · Jul 3, 2026
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
MT Newswires · Jun 30, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About SNN
SNN is led by CEO Deepak S Nath, employs 17,818 people, headquartered in Watford, GB, publicly traded since 1999.
SNN stock trades at $28.97 with a market capitalization of $12.17B. The stock is valued at a price-to-earnings (P/E) ratio of 21.23, price-to-book of 12.19, price-to-sales of 2.05. Over the past 52 weeks the stock has ranged between $28.65 and $38.79, and currently trades 25.3% below its 52-week high. It pays a dividend yielding 2.57%.
On profitability, SNN generates a return on equity (ROE) of 11.84%, return on capital employed of 19.00%, an operating margin of 16.27%, a net profit margin of 10.14%.